RELX Plc is a global provider of information-based analytics and decision tools for professional and business customers across professional, scientific, risk, legal, and exhibitions sectors. The company delivers scientific, technical and medical information and analytics through Elsevier, including ScienceDirect with 16 million research documents, Scopus bibliographic database with over 50 million items, and Mendeley for research management; risk management solutions via LexisNexis Risk Solutions, featuring data analytics, fraud detection, identity verification, and compliance tools for insurance, financial services, governments, and corporations; legal information and analytics under LexisNexis, encompassing Lexis+AI generative AI platform, Protégé AI assistant, and databases with 119 billion documents; and exhibitions through RX, organizing 500 shows for 140,000 exhibitors and 7 million visitors, including events like New York Comic Con. Founded in 1993 through the merger of Reed International and Elsevier NV and headquartered in London, England, RELX Plc operates in 40 countries and serves customers in over 180 nations. In the first half of 2025, the company completed three acquisitions for £262 million total consideration to bolster its portfolio, alongside two small disposals, ongoing share buybacks totaling over £1 billion from a £1.5 billion program, and strong revenue growth driven by AI-enhanced products like Lexis+AI and expansions in high-growth markets.